Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade. The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Endocrine Society
2016-06-01
|
| Серии: | Endocrinology and Metabolism |
| Предметы: | |
| Online-ссылка: | http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-31-258.pdf |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|